Zimbabwe, where HIV has led to tens of thousands of deaths over the past two decades, is one of the first countries to roll out lenacapavir, a long-acting drug that authorities hope will slow new ...

Over 95% of the world's adult population is infected with Epstein-Barr virus (EBV), but most people never realize it. The infection often causes few symptoms and then stays in the body for life.

HIV has long been thought of as a disease that primarily impacts gay men. That's wrongheaded.

Zimbabwe's health authorities on Thursday began administering the long-acting HIV prevention drug lenacapavir, making the ...

It has taken about two decades, but the world finally has a new, longer-acting injectable drug for HIV prevention. Yesterday, Kenya received 21,000 doses of Lenacapavir, also known as LEN, with about ...

Fighting against an illness with no treatment and institutional racism, Black queer communities had to look inward for support.